Free Trial
OTCMKTS:MKKGY

Merck KGaA (MKKGY) Stock Price, News & Analysis

Merck KGaA logo
$25.29 0.00 (0.00%)
As of 03:19 PM Eastern

About Merck KGaA Stock (OTCMKTS:MKKGY)

Key Stats

Today's Range
$25.16
$25.37
50-Day Range
$24.53
$26.81
52-Week Range
$24.32
$39.17
Volume
87,174 shs
Average Volume
142,302 shs
Market Capitalization
$16.34 billion
P/E Ratio
10.63
Dividend Yield
1.34%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Merck KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

MKKGY MarketRank™: 

Merck KGaA scored higher than 52% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Merck KGaA are expected to grow by 9.63% in the coming year, from $1.87 to $2.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Merck KGaA is 10.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.70.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Merck KGaA is 10.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.31.

  • Price to Earnings Growth Ratio

    Merck KGaA has a PEG Ratio of 3.11. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Merck KGaA has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Merck KGaA's valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of Merck KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Merck KGaA has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Merck KGaA has recently increased by 8.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Merck KGaA pays a meaningful dividend of 1.34%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Merck KGaA does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Merck KGaA is 14.29%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Merck KGaA will have a dividend payout ratio of 16.59% next year. This indicates that Merck KGaA will be able to sustain or increase its dividend.

  • Read more about Merck KGaA's dividend.
  • Percentage of Shares Shorted

    0.02% of the float of Merck KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Merck KGaA has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Merck KGaA has recently increased by 8.13%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Merck KGaA has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Merck KGaA this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Merck KGaA insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 0.10% of the stock of Merck KGaA is held by institutions.

  • Read more about Merck KGaA's insider trading history.
Receive MKKGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MKKGY Stock News Headlines

“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
Is Wall Street Bullish or Bearish on Merck Stock?
See More Headlines

MKKGY Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $28.63 at the beginning of the year. Since then, MKKGY shares have decreased by 11.7% and is now trading at $25.29.

Merck KGaA (OTCMKTS:MKKGY) issued its quarterly earnings results on Thursday, August, 7th. The company reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.51 by $0.06. The company had revenue of $6.11 billion for the quarter, compared to the consensus estimate of $5.34 billion. Merck KGaA had a net margin of 13.49% and a trailing twelve-month return on equity of 9.81%.

Shares of MKKGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/07/2025
Today
8/28/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:MKKGY
Previous Symbol
OTCMKTS:MKKGY
CIK
N/A
Employees
62,557
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$2.38
Trailing P/E Ratio
10.66
Forward P/E Ratio
13.57
P/E Growth
3.11
Net Income
$3.00 billion
Net Margins
13.49%
Pretax Margin
16.86%
Return on Equity
9.81%
Return on Assets
5.73%

Debt

Debt-to-Equity Ratio
0.23
Current Ratio
1.31
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$22.57 billion
Price / Sales
0.73
Cash Flow
$8.19 per share
Price / Cash Flow
3.10
Book Value
$50.22 per share
Price / Book
0.51

Miscellaneous

Outstanding Shares
646,210,000
Free Float
N/A
Market Cap
$16.40 billion
Optionable
Not Optionable
Beta
0.91

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:MKKGY) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners